D-0169-2019 Class II Terminated
FDA drug recall D-0169-2019 was initiated by Pharm D Solutions, LLC on Sep 10, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 264 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Nov 7, 2018
- Initiation Date
- Sep 10, 2018
- Termination Date
- Feb 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 264 vials
Product Description
Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV,Pharm D Solutions, Houston, Texas --- NDC 69699-1203-50
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide
Code Information
Lot: 03152018:12 Discard by: 6/13/2018; 04182018:08 Discard by: 7/17/2018; 04302018:94 Discard by: 7/29/2018; 03292018:44 Discard by: 6/26/2018; 05212018:95 Discard by: 8/19/2018; 06142018:46 Discard by: 9/12/2018; 05312018:37 Discard by: 8/29/2018; 06282018:80 Discard by: 9/26/2018; 07312018:12 Discard by: 10/29/2018; 07102018:53 Discard by: 10/8/2018; 08222018:18 Discard by: 11/20/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0169-2019
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026